Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001243609 | SCV001416777 | uncertain significance | X-linked agammaglobulinemia with growth hormone deficiency | 2019-10-25 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature as a germline variant in individuals with BTK-related conditions. ClinVar contains an entry for this variant (Variation ID: 376204). This sequence change replaces cysteine with serine at codon 481 of the BTK protein (p.Cys481Ser). The cysteine residue is highly conserved and there is a moderate physicochemical difference between cysteine and serine. This variant is not present in population databases (ExAC no frequency). |
Clinical Genetics and Genomics, |
RCV001269602 | SCV001449699 | pathogenic | not provided | 2017-08-18 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001269602 | SCV005411466 | uncertain significance | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | PP2, PM1, PM2 |